You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Hodgkin Lymphoma Treatment Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Market Analysis and Insights: Global Hodgkin Lymphoma Treatment Market
The research report studies the Hodgkin Lymphoma Treatment market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Hodgkin Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Hodgkin Lymphoma Treatment Scope and Segment
The global Hodgkin Lymphoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hodgkin Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Alocrest
ANK Program
Azacitidine
BMS-986016
BPX-501
Others
by Application, this report covers the following segments
Hospital
Clinic
Research Center
Global Hodgkin Lymphoma Treatment market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Hodgkin Lymphoma Treatment key players in this market include:
Cell Medica Limited
Cellular Biomedicine Group, Inc.
Constellation Pharmaceuticals, Inc.
Curis, Inc.
Faron Pharmaceuticals Oy
Fate Therapeutics, Inc.
Gamida Cell Ltd.
Gilead Sciences, Inc.
Incyte Corporation
Merck & Co., Inc.
Mirati Therapeutics Inc.
Molecular Templates Inc.
NantKwest, Inc.
1 Market Overview of Hodgkin Lymphoma Treatment
1.1 Hodgkin Lymphoma Treatment Market Overview
1.1.1 Hodgkin Lymphoma Treatment Product Scope
1.1.2 Hodgkin Lymphoma Treatment Market Status and Outlook
1.2 Global Hodgkin Lymphoma Treatment Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Hodgkin Lymphoma Treatment Market Size by Region (2016-2027)
1.4 Global Hodgkin Lymphoma Treatment Historic Market Size by Region (2016-2021)
1.5 Global Hodgkin Lymphoma Treatment Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Hodgkin Lymphoma Treatment Market Size (2016-2027)
1.6.1 North America Hodgkin Lymphoma Treatment Market Size (2016-2027)
1.6.2 Europe Hodgkin Lymphoma Treatment Market Size (2016-2027)
1.6.3 Asia-Pacific Hodgkin Lymphoma Treatment Market Size (2016-2027)
1.6.4 Latin America Hodgkin Lymphoma Treatment Market Size (2016-2027)
1.6.5 Middle East & Africa Hodgkin Lymphoma Treatment Market Size (2016-2027)
2 Hodgkin Lymphoma Treatment Market Overview by Type
2.1 Global Hodgkin Lymphoma Treatment Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Hodgkin Lymphoma Treatment Historic Market Size by Type (2016-2021)
2.3 Global Hodgkin Lymphoma Treatment Forecasted Market Size by Type (2022-2027)
2.4 Alocrest
2.5 ANK Program
2.6 Azacitidine
2.7 BMS-986016
2.8 BPX-501
2.9 Others
3 Hodgkin Lymphoma Treatment Market Overview by Application
3.1 Global Hodgkin Lymphoma Treatment Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Hodgkin Lymphoma Treatment Historic Market Size by Application (2016-2021)
3.3 Global Hodgkin Lymphoma Treatment Forecasted Market Size by Application (2022-2027)
3.4 Hospital
3.5 Clinic
3.6 Research Center
4 Hodgkin Lymphoma Treatment Competition Analysis by Players
4.1 Global Hodgkin Lymphoma Treatment Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hodgkin Lymphoma Treatment as of 2020)
4.3 Date of Key Players Enter into Hodgkin Lymphoma Treatment Market
4.4 Global Top Players Hodgkin Lymphoma Treatment Headquarters and Area Served
4.5 Key Players Hodgkin Lymphoma Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Hodgkin Lymphoma Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Cell Medica Limited
5.1.1 Cell Medica Limited Profile
5.1.2 Cell Medica Limited Main Business
5.1.3 Cell Medica Limited Hodgkin Lymphoma Treatment Products, Services and Solutions
5.1.4 Cell Medica Limited Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.1.5 Cell Medica Limited Recent Developments
5.2 Cellular Biomedicine Group Inc.
5.2.1 Cellular Biomedicine Group Inc. Profile
5.2.2 Cellular Biomedicine Group Inc. Main Business
5.2.3 Cellular Biomedicine Group Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
5.2.4 Cellular Biomedicine Group Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.2.5 Cellular Biomedicine Group Inc. Recent Developments
5.3 Constellation Pharmaceuticals Inc.
5.3.1 Constellation Pharmaceuticals Inc. Profile
5.3.2 Constellation Pharmaceuticals Inc. Main Business
5.3.3 Constellation Pharmaceuticals Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
5.3.4 Constellation Pharmaceuticals Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.3.5 Curis Inc. Recent Developments
5.4 Curis Inc.
5.4.1 Curis Inc. Profile
5.4.2 Curis Inc. Main Business
5.4.3 Curis Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
5.4.4 Curis Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.4.5 Curis Inc. Recent Developments
5.5 Faron Pharmaceuticals Oy
5.5.1 Faron Pharmaceuticals Oy Profile
5.5.2 Faron Pharmaceuticals Oy Main Business
5.5.3 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Products, Services and Solutions
5.5.4 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.5.5 Faron Pharmaceuticals Oy Recent Developments
5.6 Fate Therapeutics Inc.
5.6.1 Fate Therapeutics Inc. Profile
5.6.2 Fate Therapeutics Inc. Main Business
5.6.3 Fate Therapeutics Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
5.6.4 Fate Therapeutics Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.6.5 Fate Therapeutics Inc. Recent Developments
5.7 Gamida Cell Ltd.
5.7.1 Gamida Cell Ltd. Profile
5.7.2 Gamida Cell Ltd. Main Business
5.7.3 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Products, Services and Solutions
5.7.4 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.7.5 Gamida Cell Ltd. Recent Developments
5.8 Gilead Sciences Inc.
5.8.1 Gilead Sciences Inc. Profile
5.8.2 Gilead Sciences Inc. Main Business
5.8.3 Gilead Sciences Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
5.8.4 Gilead Sciences Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.8.5 Gilead Sciences Inc. Recent Developments
5.9 Incyte Corporation
5.9.1 Incyte Corporation Profile
5.9.2 Incyte Corporation Main Business
5.9.3 Incyte Corporation Hodgkin Lymphoma Treatment Products, Services and Solutions
5.9.4 Incyte Corporation Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.9.5 Incyte Corporation Recent Developments
5.10 Merck & Co. Inc.
5.10.1 Merck & Co. Inc. Profile
5.10.2 Merck & Co. Inc. Main Business
5.10.3 Merck & Co. Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
5.10.4 Merck & Co. Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.10.5 Merck & Co. Inc. Recent Developments
5.11 Mirati Therapeutics Inc.
5.11.1 Mirati Therapeutics Inc. Profile
5.11.2 Mirati Therapeutics Inc. Main Business
5.11.3 Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
5.11.4 Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.11.5 Mirati Therapeutics Inc. Recent Developments
5.12 Molecular Templates Inc.
5.12.1 Molecular Templates Inc. Profile
5.12.2 Molecular Templates Inc. Main Business
5.12.3 Molecular Templates Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
5.12.4 Molecular Templates Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.12.5 Molecular Templates Inc. Recent Developments
5.13 NantKwest Inc.
5.13.1 NantKwest Inc. Profile
5.13.2 NantKwest Inc. Main Business
5.13.3 NantKwest Inc. Hodgkin Lymphoma Treatment Products, Services and Solutions
5.13.4 NantKwest Inc. Hodgkin Lymphoma Treatment Revenue (US$ Million) & (2016-2021)
5.13.5 NantKwest Inc. Recent Developments
6 North America
6.1 North America Hodgkin Lymphoma Treatment Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Hodgkin Lymphoma Treatment Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Hodgkin Lymphoma Treatment Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Hodgkin Lymphoma Treatment Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Hodgkin Lymphoma Treatment Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Hodgkin Lymphoma Treatment Market Dynamics
11.1 Hodgkin Lymphoma Treatment Industry Trends
11.2 Hodgkin Lymphoma Treatment Market Drivers
11.3 Hodgkin Lymphoma Treatment Market Challenges
11.4 Hodgkin Lymphoma Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 125